PFM Health Sciences’s Pfizer PFE Stock Holding History

PFM Health Sciences’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-976,004	Closed	-$34M	–	99
2020 Q3	$34M	Buy	+976,004	New	+$34.2M	1.57%	21
2019 Q3	–	Sell	-1,394,020	Closed	-$57.3M	–	93
2019 Q2	$57.3M	Buy	+1,394,020	New	+$55.4M	1.09%	29
2017 Q4	–	Sell	-5,920,529	Closed	-$201M	–	95
2017 Q3	$201M	Buy	+5,920,529	New	+$190M	3.94%	3
2015 Q4	–	Sell	-2,326,600	Closed	-$265K	–	82
2015 Q3	$265K	Buy	+2,326,600	New	+$74.6M	0.01%	72

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PFM Health Sciences's PFE Position: Q3 2022 in Review

PFM Health Sciences sold out of Pfizer (PFE) in Q3 2022, closing a stake of 1,343,384 shares — an estimated $70.4M sold.

PFM Health Sciences first reported a position in PFE in Q2 2013 and held it in 19 quarters. The position peaked at $297M in Q2 2013. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

PFM Health Sciences reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
PFM Health Sciences sold 1,343,384 Pfizer shares in Q3 2022, an estimated $70.4M.
PFM Health Sciences first reported a position in Pfizer in Q2 2013 and held it in 19 quarters.
PFM Health Sciences's Pfizer position peaked at $297M in Q2 2013.
3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on PFM Health Sciences's 13F filing for Q3 2022, filed 14 Nov 2022.